Schedule 13G ownership disclosure
Tango Therapeutics Inc
Common Stock, par value $0.001 per share · CUSIP: 87583X109
Event date: 2025-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- TCG Crossover GP II, L.P.
Shares: 13,521,839 · Class: 9.99%
- TCG Crossover Fund II, L.P.
Shares: 13,521,839 · Class: 9.99%
- Chen Yu
Shares: 13,521,839 · Class: 9.99%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-26-054743
- Form type
- SCHEDULE 13G/A
- Filer
- TCG Crossover GP II, LLC
- CIK
- CIK 1969280
- Filed
- Feb 17, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership